Recurrent Pancreatic Carcinoma
Also known as:Pancreatic carcinoma recurrent/Pancreas carcinoma recurrent/Pancreatic cancer recurrent
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB01373 | Calcium | 0 | Completed | 1 |
DB04690 | Camptothecin | 0 | Completed | 1 |
DB00544 | Fluorouracil | 0 | Completed | 1 |
DB00762 | Irinotecan | 0 | Completed | 1 |
DB00650 | Leucovorin | 0 | Completed | 1 |
DB11596 | Levoleucovorin | 0 | Completed | 1 |
DB00526 | Oxaliplatin | 0 | Completed | 1 |
DB08916 | Afatinib | 1 | Completed | 1 |
DB01101 | Capecitabine | 1 | Completed | 1 |
DB04849 | Cediranib | 1 | Completed | 1 |
DB00531 | Cyclophosphamide | 1 | Terminated | 1 |
DB01254 | Dasatinib | 1 | Active Not Recruiting | 1 |
DB12021 | Dinaciclib | 1 | Completed | 1 |
DB11714 | Durvalumab | 1 | Active Not Recruiting | 1 |
DB00530 | Erlotinib | 1 | Active Not Recruiting | 2 |
DB00099 | Filgrastim | 1 | Terminated | 1 |
DB00441 | Gemcitabine | 1 | Active Not Recruiting | 2 |
DB00441 | Gemcitabine | 1 | Completed | 1 |
DB11918 | Guadecitabine | 1 | Active Not Recruiting | 1 |
DB12303 | Motolimod | 1 | Terminated | 1 |
DB00019 | Pegfilgrastim | 1 | Terminated | 1 |
DB09037 | Pembrolizumab | 1 | Active Not Recruiting | 1 |
DB11870 | RG-4733 | 1 | Completed | 1 |
DB06176 | Romidepsin | 1 | Active Not Recruiting | 1 |
DB00398 | Sorafenib | 1 | Completed | 1 |
DB08828 | Vismodegib | 1 | Active Not Recruiting | 1 |
DB02546 | Vorinostat | 1 | Completed | 1 |
DB12981 | XL-888 | 1 | Active Not Recruiting | 1 |
DB00062 | Albumin human | 1 / 2 | Completed | 1 |
DB00041 | Aldesleukin | 1 / 2 | Completed | 1 |
DB01373 | Calcium | 1 / 2 | Completed | 1 |
DB04690 | Camptothecin | 1 / 2 | Completed | 1 |
DB00693 | Fluorescein | 1 / 2 | Completed | 1 |
DB00544 | Fluorouracil | 1 / 2 | Completed | 1 |
DB00441 | Gemcitabine | 1 / 2 | Completed | 1 |
DB00762 | Irinotecan | 1 / 2 | Completed | 1 |
DB00650 | Leucovorin | 1 / 2 | Completed | 1 |
DB11596 | Levoleucovorin | 1 / 2 | Completed | 1 |
DB00526 | Oxaliplatin | 1 / 2 | Completed | 1 |
DB00892 | Oxybuprocaine | 1 / 2 | Completed | 1 |
DB01229 | Paclitaxel | 1 / 2 | Completed | 1 |
DB00020 | Sargramostim | 1 / 2 | Completed | 1 |
DB11740 | Adavosertib | 2 | Active Not Recruiting | 1 |
DB08916 | Afatinib | 2 | Active Not Recruiting | 1 |
DB11967 | Binimetinib | 2 | Active Not Recruiting | 1 |
DB11967 | Binimetinib | 2 | Recruiting | 1 |
DB01373 | Calcium | 2 | Active Not Recruiting | 1 |
DB04690 | Camptothecin | 2 | Active Not Recruiting | 1 |
DB01101 | Capecitabine | 2 | Recruiting | 1 |
DB12218 | Capivasertib | 2 | Active Not Recruiting | 1 |
DB00958 | Carboplatin | 2 | Completed | 1 |
DB14547 | Chloride ion | 2 | Active Not Recruiting | 1 |
DB00515 | Cisplatin | 2 | Active Not Recruiting | 1 |
DB12483 | Copanlisib | 2 | Active Not Recruiting | 1 |
DB08865 | Crizotinib | 2 | Active Not Recruiting | 1 |
DB08912 | Dabrafenib | 2 | Active Not Recruiting | 1 |
DB01254 | Dasatinib | 2 | Active Not Recruiting | 1 |
DB12282 | Defactinib | 2 | Active Not Recruiting | 1 |
DB11718 | Encorafenib | 2 | Recruiting | 1 |
DB12147 | Erdafitinib | 2 | Active Not Recruiting | 1 |
DB00693 | Fluorescein | 2 | Completed | 1 |
DB00544 | Fluorouracil | 2 | Active Not Recruiting | 1 |
DB00544 | Fluorouracil | 2 | Completed | 1 |
DB00544 | Fluorouracil | 2 | Recruiting | 1 |
DB11795 | GSK-2636771 | 2 | Active Not Recruiting | 1 |
DB00441 | Gemcitabine | 2 | Active Not Recruiting | 1 |
DB00441 | Gemcitabine | 2 | Completed | 1 |
DB11743 | Ipatasertib | 2 | Active Not Recruiting | 1 |
DB00762 | Irinotecan | 2 | Active Not Recruiting | 1 |
DB14723 | Larotrectinib | 2 | Active Not Recruiting | 1 |
DB00650 | Leucovorin | 2 | Active Not Recruiting | 1 |
DB11596 | Levoleucovorin | 2 | Active Not Recruiting | 1 |
DB15994 | 甲烷 | 2 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
DB09330 | Osimertinib | 2 | Active Not Recruiting | 1 |
DB00526 | Oxaliplatin | 2 | Completed | 1 |
DB00892 | Oxybuprocaine | 2 | Completed | 1 |
DB01229 | Paclitaxel | 2 | Completed | 1 |
DB09073 | Palbociclib | 2 | Active Not Recruiting | 1 |
DB17284 | Pelareorep | 2 | Completed | 1 |
DB06366 | Pertuzumab | 2 | Active Not Recruiting | 1 |
DB12257 | Platinum | 2 | Active Not Recruiting | 1 |
DB14851 | Relatlimab | 2 | Active Not Recruiting | 1 |
DB11836 | Sapanisertib | 2 | Active Not Recruiting | 1 |
DB11689 | Selumetinib | 2 | Completed | 1 |
DB14546 | Sulfate ion | 2 | Active Not Recruiting | 1 |
DB01268 | Sunitinib | 2 | Active Not Recruiting | 1 |
DB12108 | Taselisib | 2 | Active Not Recruiting | 1 |
DB08911 | Trametinib | 2 | Active Not Recruiting | 1 |
DB00072 | Trastuzumab | 2 | Active Not Recruiting | 1 |
DB05773 | Trastuzumab emtansine | 2 | Active Not Recruiting | 1 |
DB00135 | Tyrosine | 2 | Active Not Recruiting | 1 |
DB13930 | Ulixertinib | 2 | Active Not Recruiting | 1 |
DB07232 | Veliparib | 2 | Active Not Recruiting | 2 |
DB08828 | Vismodegib | 2 | Active Not Recruiting | 1 |
DB08828 | Vismodegib | 2 | Completed | 1 |
DB00399 | Zoledronic acid | 2 | Recruiting | 1 |